Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
N-[[3-Fluoro-4-ethoxy-pyrid-2-yl]ethyl]-N'-[5-nitrilomethyl-pyridyl]-thiourea is an experimental small molecule compound. It features a thiourea core linking two substituted pyridine rings, one with a fluoro and ethoxy group and the other with a nitrilomethyl substituent. The compound has been referenced in structural biology databases (PDB ligand FPT, PDB entry 1dtq), but there is no evidence of clinical development or approved therapeutic use. Its mechanism of action, biological targets, and potential indications are not described in public drug or trial registries. It is primarily noted as a chemical probe or research tool rather than as an active pharmaceutical ingredient for any disease.[3][9]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on n-[[3-fluoro-4-ethoxy-pyrid-2-yl]ethyl]-n'-[5-nitrilomethyl-pyridyl]-thiourea.